This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Eli Lilly and Company. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Seamus Patrick Brennan: Innovator in Insulin Compounds
Introduction
Seamus Patrick Brennan is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of medicine, particularly in the development of insulin compounds. His innovative work has led to the creation of a patent that addresses critical needs in diabetes management.
Latest Patents
Brennan holds a patent for "Extended Time Action Acylated Insulin Compounds." This invention aims to improve the efficacy and duration of insulin action, providing better management options for individuals with diabetes. His patent is a testament to his dedication to advancing medical science and improving patient outcomes.
Career Highlights
Seamus Patrick Brennan is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His role at Eli Lilly has allowed him to work on groundbreaking projects that have the potential to transform diabetes treatment.
Collaborations
Brennan has collaborated with esteemed colleagues such as Wen Liu and Vladislav Kisselev. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and development efforts.
Conclusion
Seamus Patrick Brennan is a distinguished inventor whose work in insulin compounds has made a significant impact on diabetes management. His contributions to the field exemplify the importance of innovation in healthcare.